Skip to content

A clinical study to evaluate the effect of Saindhavadya taila purana over Kasisadi taila purana in the management of Abhyantara arshas (Internal haemorrhoids)

A controlled clinical study to evaluate the effect of Saindhavadya taila purana over Kasisadi taila purana in the management of Abhyantara arshas (Internal haemorrhoids) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072482
Enrollment
40
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Sponsors

Dr Mallikarjun Kokatanur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients with Abhyantara arsha [1st and 2nd degree internal haemorrhoids] age between 21 to 65 years of either gender with maximum 3 internal haemorrhoids. (2) Patients with Hb% more than 8 gm per dl.

Exclusion criteria

Exclusion criteria: (1) External and Thrombosed pile mass. (2) 3rd and 4th degree Internal haemorrhoids. (3) Patient with HIV and HBsAg positive. (4) Patients with Diabetes.

Design outcomes

Primary

MeasureTime frame
Assessment of Objective parameter- Size of Mamsankura [pile mass] , Number of Mamsankura [pile mass]Timepoint: 3 weeks

Secondary

MeasureTime frame
Assessment of- - Raktasrava (Bleeding) - Vibandha (Constipation)Timepoint: Total Study duration – 21 days. Treatment duration – 07 days. Follow up – 14 days. Assessment days- 1st day [Before treatment] 7th day [After treatment] 14th day [During Follow up 1] 21th day [During Follow up 2].

Countries

India

Contacts

Public ContactDr B S Savadi

Shree Jagadguru Gavisiddeshwara Ayurvedic Medical College and Hospital, Koppal

savadi.savitha@gmail.com9845646885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026